RAPT Therapeutics, Inc.

RAPT Therapeutics, Inc.verified

RAPT

Price:

$1.73

Market Cap:

$60.48M

RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead oncology drug candidate is FLX475, an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. It also focuses on the development o...[Read more]

Industry

Biotechnology

IPO Date

2019-10-31

Stock Exchange

NASDAQ

Ticker

RAPT

The Dividend Yield as of December 2024 (TTM) for RAPT Therapeutics, Inc. (RAPT) is 0%

According to RAPT Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

RAPT Therapeutics, Inc. (RAPT) Historical Dividend Yield (quarterly & annually)

How has RAPT Dividend Yield performed in the past?

The mean historical Dividend Yield of RAPT Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), RAPT's Dividend Yield was at its highest in in the March 2018 quarter at 0%. The Dividend Yield was at its lowest in in the March 2018 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

RAPT Therapeutics, Inc. (RAPT) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of RAPT Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%

RAPT Therapeutics, Inc. (RAPT) Average Dividend Yield

How has RAPT Dividend Yield performed in the past?

The current Dividend Yield of RAPT Therapeutics, Inc. (RAPT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

RAPT Therapeutics, Inc. (RAPT) Dividend Yield vs. Peers

How is RAPT’s Dividend Yield compared to its peers?

RAPT Therapeutics, Inc.’s Dividend Yield is less than Connect Biopharma Holdings Limited (0%), less than Tyra Biosciences, Inc. (0%), less than Xilio Therapeutics, Inc. (0%), less than Mineralys Therapeutics, Inc. (0%), less than Molecular Partners AG (0%), less than AN2 Therapeutics, Inc. (0%), less than Pharvaris N.V. (0%), less than PepGen Inc. (0%), less than Monte Rosa Therapeutics, Inc. (0%), less than Design Therapeutics, Inc. (0%), less than Werewolf Therapeutics, Inc. (0%), less than Ikena Oncology, Inc. (0%), less than Stoke Therapeutics, Inc. (0%), less than Anebulo Pharmaceuticals, Inc. (0%), less than PMV Pharmaceuticals, Inc. (0%), less than Eliem Therapeutics, Inc. (0%), less than HCW Biologics Inc. (0%), less than Relay Therapeutics, Inc. (0%), less than Pliant Therapeutics, Inc. (0%), less than Black Diamond Therapeutics, Inc. (0%), less than Arvinas, Inc. (0%),

Build a custom stock screener for RAPT Therapeutics, Inc. (RAPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RAPT Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RAPT Therapeutics, Inc. (RAPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RAPT Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is RAPT Therapeutics, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for RAPT Therapeutics, Inc. (RAPT)?

What is the highest Dividend Yield for RAPT Therapeutics, Inc. (RAPT)?

What is the 3-year average Dividend Yield for RAPT Therapeutics, Inc. (RAPT)?

What is the 5-year average Dividend Yield for RAPT Therapeutics, Inc. (RAPT)?

How does the current Dividend Yield for RAPT Therapeutics, Inc. (RAPT) compare to its historical average?